Fundraising Fox

SQZ Biotechnologies

Watertown, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

AW
Amy W. SchulmanExecutive Officer, Director
MM
Mark Murcko, Ph.D.Director
KE
Kris ElverumExecutive Officer
GA
Garry A. NicholsonDirector
HB
Howard BernsteinExecutive Officer
RS
Robert S. Langer, Sc.D.Director
AS
Armon Sharei, Ph.D.Executive Officer, Director
JF
Jonathan FlemingDirector
EM
Eric MoessingerDirector
KF
Klavs F. Jensen, Ph.D.Director

Investors · 1

Veltro ArgentoreportedStamford

Reported raises · per SEC filings

Form D private placements
▶$66.3MraisedJun 2020 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard Bernstein, M.D., Ph.D.Executive Officer
  • Oliver Rosen, M.D.Executive Officer
  • David FirstExecutive Officer
  • Armon Sharei, Ph.D.Executive Officer, Director
  • Eric MoessingerDirector
  • Alexandra BalcomExecutive Officer
  • Teri LoxamExecutive Officer
  • Pushkal GargDirector
  • Marc EliaDirector
  • Zafrira AvnurDirector
  • Lawrence KnopfExecutive Officer
  • Klavs F. Jensen, Ph.D.Director
  • Amy W. SchulmanDirector
  • Jonathan FlemingDirector
Offering amount
$70.2M
Amount sold
$66.3M
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$71.3MraisedNov 2019 · 48 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan FlemingDirector
  • Armon Sharei, Ph.D.Executive Officer, Director
  • Robert Langer, Sc.D.Director
  • Klavs F. Jensen, Ph.D.Director
  • Amy W. SchulmanDirector
  • Pushkal GargDirector
  • Eric MoessingerDirector
  • Garry A. NicholsonDirector
  • Marc EliaDirector
  • Zafrira AvnurDirector
  • Alex BalcomExecutive Officer
Amount sold
$71.3M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.1MraisedDec 2016 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy W. SchulmanExecutive Officer, Director
  • Mark Murcko, Ph.D.Director
  • Kris ElverumExecutive Officer
  • Garry A. NicholsonDirector
  • Howard BernsteinExecutive Officer
  • Robert S. Langer, Sc.D.Director
  • Armon Sharei, Ph.D.Executive Officer, Director
  • Jonathan FlemingDirector
  • Eric MoessingerDirector
  • Klavs F. Jensen, Ph.D.Director
Offering amount
$24.1M
Amount sold
$24.1M
First sale
Sep 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJul 2015 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan FlemingDirector
  • Klavs F. Jensen, Ph.D.Director
  • Armon Sharei, Ph.D.Executive Officer, Director
  • Robert Langer, Ph.D.Director
  • Amy W. SchulmanDirector
Offering amount
$5.1M
Amount sold
$5.1M
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.